THRDライブシグナル | Getagraph.comで利益を最大化

買う 153877 min ago

@ $9.00

発行日: 14 2月 2024 @ 02:30

リターン: 50.03%

前回のシグナル: 2月 7 - 03:49

前回のシグナル: 売る

リターン: -2.39 %

Live Chart Being Loaded With Signals

Commentary (30 5月 2024 @ 22:58):

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases...

Stats
本日の出来高	1 946.00
平均出来高	151 632
時価総額	552.94M
EPS	$0.195 ( 2024-05-16 )
次の収益日	( $-0.340 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-18.00
ATR14	$0.0300 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-20	Dittman Jennifer	Sell	1 042	Employee Stock Option (right to buy)
2024-05-20	Dittman Jennifer	Sell	1 042	Common Stock
2024-05-20	Dittman Jennifer	Sell	1 042	Common Stock
2024-05-16	Dinsmore Christopher	Buy	210 000	Employee Stock Option (right to buy)
2024-05-16	Dinsmore Christopher	Buy	0

INSIDER POWER
46.58
Last 96 transactions
Buy: 6 105 206 \| Sell: 2 714 663

ボリューム相関

長: 0.18 (neutral)

短: -0.58 (weak negative)

Signal:(48.24) Neutral

Third Harmonic Bio, Inc. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Third Harmonic Bio, Inc. 相関 - 通貨/商品

-0.02
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.23
( neutral )

-0.21
( neutral )

0.34
( neutral )

Third Harmonic Bio, Inc. 財務諸表

Annual	2023
収益:	$0
総利益:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2023
収益:	$0
総利益:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2022
収益:	$0
総利益:	$-38 000.00 (0.00 %)
EPS:	$-0.960

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.730

Financial Reports:

No articles found.

Third Harmonic Bio, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.